Cervical CA screening Flashcards

(38 cards)

1
Q

________ is the fourth most common cause
of cancer death in women worldwide, especially in
developing countries.

A

Cervical cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

It is the most common cancer
in women in Eastern and Middle Africa, and the _______
most common in Australian women

A

12 th

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Australia has
the second lowest incidence of cervical cancer in
the world as a result of the success of the _______

A

National

Cervical Screening Program introduced in 1991

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The most common cervical cancer is ________ accounting for 80% of cases

A
squamous
cell carcinoma (SCC),
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

________ is less common and more difficult

to diagnose because it starts higher in the cervix.

A

Adenocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cervical cancer almost exclusively occurs in women
who have been sexually active, due to exposure to
_________

A

human papillomavirus (HPV).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Of the genital HPV types, 15 are
classified as ‘high risk’, as they are associated
with _________

A
anogenital cancer (including squamous and
adenocarcinoma of the cervix).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

HPV _________ are responsible for around 70% of invasive cervical cancers and 50% of high-grade lesions

A

16 and 18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Most cervical HPV infections are cleared or suppressed by __________

A

cell-mediated

immunity within 1–2 years of exposure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The focus of attention is the__________ where columnar cells lining the endocervical
canal undergo metaplasia to squamous cells in
the region of the squamocolumnar junction.

A

transformation zone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

It is important clinically to realise that this transformation
zone can extend with progressive metaplasia of
columnar epithelium and so the squamocolumnar
junction may recede into the ________

A

endocervical canal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

________ represent an acute HPV infection of the transformation zone.

A

Low-grade squamous intraepithelial lesions (LSILs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

T or F

HSILs may return to normal, persist or eventually
progress to invasive cervical cancer

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The average duration between HSILs and cancer is between _________

A

10 and 15 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Current cervical screening uses ________

A

cytology from the
Papanicolaou smear, or Pap test, as the screening
tool

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cervical CA screening

• Commence cervical screening at _________after first sexual intercourse, whichever is later

• Perform every 2 years and cease at ______ in
those who have had two normal Pap tests within
the last 5 years

A

18–20 years or 2 years

70 years

17
Q

Screen women over 70 years if _______

A

they request it or

if they have never had a Pap test

18
Q

Women with postcoital or persistent

intermenstrual bleeding require a ______

A

diagnostic Pap
test and referral for colposcopy irrespective of
the resul

19
Q

Screening in particular groups

Hysterectomy . Cervical screening is still required if
__________

A

the cervix was not completely removed.

20
Q

vaginal vault Pap tests are indicated if there is a
1
2
3

A
  1. history of gynaecological dysplasia or malignancy, or
  2. exposure to diethylstilboestrol in utero, as well as in
  3. immunosuppressed women.
21
Q

Screening in particular groups

Pregnancy. If due, cervical screening is still
recommended and can be safely performed until
________

A

24 weeks gestation

22
Q

T or F

Pap tests have been associated
with an increased rate of miscarriage in the first and
second trimesters

A

False

have not

23
Q

Postmenopausal women. If not taking hormone

replacement therapy, postmenopausal women may benefit from a _______

A

short course of topical vaginal oestrogen

before their Pap test

24
Q

Special attention should be focused on screening the
following women:

• \_\_\_\_\_\_\_\_\_
(mortality of cervical cancer five times that of
other women in Australia)
• Women from \_\_\_\_\_\_\_
• Women in\_\_\_\_\_\_
• Lesbian and bisexual women
• Women with disabilities
A

Aboriginal and Torres Strait Islander women

non-English-speaking backgrounds

rural and remote areas

25
What are the smear taking instruments
— Ayer’s spatula, wooden or plastic — Cervex sampler broom — Cervex-Brush Combi — endocervical brush
26
pregnancy—avoid use of the ____ and ____
endocervical brush and the Cervex-Brush Combi
27
The __________provides better exposure of the vulva but requires more manipulation of the patient.
Sims exaggerated left lateral | position
28
cervix is situated in the _______
upper sixth of the anterior vaginal | wall (not in the apex of the vagina).
29
A__________ is normal in most premenopausal women and was formerly incorrectly called an erosion.
cervical ectropion
30
A woman treated for HSIL should have a ______
colposcopy | and cervical cytology at 4–6 months after treatment
31
three-dose schedule of the quadrivalent HPV vaccine | that protects against:
HPV types 16 and 18 (high risk for cervical cancer) and types 6 and 11 (which cause genital warts).
32
Currently, the HPV vaccine (Gardasil®) is administered through the National Immunisation Program to __________
males and females aged 12–13 years
33
Women who have been immunised still require | cervical screening because ________
the vaccine does not | prevent all HPV types that cause cervical cancer
34
Negative smear—no endocervical cells_______ Negative smear—inflammatory cells ______ Unsatisfactory smear________
Repeat in 2 years. Repeat test in 2 years. Repeat smear in 6–12 weeks (allows regeneration of cells).
35
Low-grade epithelial lesion Possible LSIL and definite LSIL
Repeat Pap test at 12 months. If the woman is 30+ years, | and has no negative cytology in previous 2–3 years, refer for colposcopy or repeat the test in 6 months
36
High-grade epithelial lesion Possible HSIL and definite HSIL______ Glandular abnormalities including adenocarcinoma in situ ____________ Invasive squamous cell carcinoma or adenocarcinoma ___________ Inconclusive—raising possibility of high-grade disease ____________
Refer for colposcopy. Refer to a gynaecologist. Refer to appropriate specialist gynaecologist or unit. Refer for colposcopy and possible biopsy
37
Pending policy approval, in 2017 it is anticipated that the cervical cancer screening test will transition from the 2-yearly Pap test to ________
5-yearly HPV DNA | testing
38
prior to HPV vaccination, the role of HPV DNA testing was limited as a screening tool because ________
as many of 25% of women aged <30 were likely to test positive for oncogenic viruses.